glp 1 and levothyroxine Why GLP-1 Agonists Are Risky For Thyroid Weight Loss Do GLP-1 Agonists Cause Thyroid

It is well established that patients with diabetes demonstrate higher susceptibility to pancreatic cancer and pancreatitis compared to non-diabetic individuals, and theoretically, sustained GLP-1 receptor activation induced by GLP-1RA therapy may potentially elevate pancreatic cancer risk [8]

lixisenatide), LEADER (Liraglutide Effects and Action in Diabetes: Evaluation of cardiovascular outcome Results

Here is the truth that most articles will not tell you

These findings add further support to a growing body of evidence that suggests that Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RAs) may modulate the human reward system by interacting with receptors in brain regions associated with dopamine signaling

These medications, known for treating diabetes and promoting weight loss, may have unexpected benefits for those with migraine disease and headache disorders

Any drug in this class could potentially carry this risk